XML 53 R27.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments Measured at Fair Value (Tables)
3 Months Ended
Mar. 28, 2020
Fair Value Disclosures  
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis Table [Text Block]
The following table presents assets (liabilities) measured at fair value on a recurring basis at March 28, 2020:
 
 
Balance Sheet
Location
 
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents (a)
 
Cash and cash equivalents/
other assets
 
$
18,169

 
$

 
$

 
$
18,169

Equity investments (b)
 
Other assets
 
32,888

 

 

 
32,888

Interest rate swaps
 
Other liabilities
 

 
(50,530
)
 

 
(50,530
)
Foreign exchange contracts
 
Other current assets/
other assets
 

 
51,188

 

 
51,188

Foreign exchange contracts
 
Accrued expenses
 

 
(7,398
)
 

 
(7,398
)
 
 
 
 
$
51,057

 
$
(6,740
)
 
$

 
$
44,317


The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2019:
 
 
Balance Sheet
Location
 
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents (a)
 
Cash and cash equivalents/
other assets
 
$
18,579

 
$

 
$

 
$
18,579

Equity investments (b)
 
Other assets
 
44,677

 

 

 
44,677

Interest rate swaps
 
Other liabilities
 

 
(11,574
)
 

 
(11,574
)
Foreign exchange contracts
 
Other current assets/
other assets
 

 
24,092

 

 
24,092

Foreign exchange contracts
 
Accrued expenses
 

 
(2,132
)
 

 
(2,132
)
 
 
 
 
$
63,256

 
$
10,386

 
$

 
$
73,642



(a)
Cash equivalents include highly liquid investments with an original maturity of less than three months.
(b)
The company has an 8.4% equity ownership interest in Marubun Corporation and a portfolio of mutual funds with quoted market prices. The company recorded an unrealized loss of $9,995 and an unrealized gain of $1,824 for the first quarter of 2020 and 2019, respectively, on equity securities held at the end of the quarter.

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block]
The effects of derivative instruments on the company’s consolidated statements of operations and other comprehensive income are as follows:
  
 
Quarter Ended
 
 
March 28,
2020

March 30,
2019
Gain (Loss) Recognized in Income
 
 
 
 
Foreign exchange contracts
 
$
4,493

 
$
3,489

Interest rate swaps
 
(1,529
)
 
(319
)
Total
 
$
2,964

 
$
3,170

Gain (Loss) Recognized in Other Comprehensive Income (Loss) before reclassifications, net of tax
 
 
 
 
Foreign exchange contracts
 
$
16,100

 
$
5,953

Interest rate swaps
 
(29,556
)
 

Total
 
$
(13,456
)
 
$
5,953


Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]  
Fair Value Disclosures  
Description of Derivative Hedging Instruments
During the first quarter of 2019, the company entered into a series of foreign exchange contracts to sell Euro and buy United States Dollars, with various maturity dates as noted in the table below:
Maturity Date
 
Notional Amount
March 2023
 
EUR 50,000
September 2024
 
EUR 50,000
April 2025
 
EUR 100,000
January 2028
 
EUR 100,000
Total
 
EUR 300,000